Keyphrases
Amoxicillin
25%
Antibiotics
25%
Antimicrobial Resistance
25%
Asia
50%
Asian Perspective
100%
Associated Diseases
100%
Bismuth
25%
Clarithromycin
100%
Clarithromycin Resistance
25%
Current Guidelines
25%
Disease Management
100%
East Asian Countries
25%
Emerging Antimicrobial Resistance
25%
Expanded Indication
25%
First-line Regimen
25%
Gastric Cancer
25%
Guideline Standards
25%
Helicobacter Pylori (H. pylori)
100%
Helicobacter Pylori Eradication
25%
Helicobacter Pylori Infection
50%
High Incidence
25%
Japanese Healthcare System
25%
Large Population
25%
Metronidazole
25%
New Guidelines
25%
Non-bismuth Quadruple
25%
Population-based Strategy
100%
Proton Pump Inhibitors
25%
Second-line Treatment
25%
Standard Triple Therapy
50%
Triple Therapy
25%
Worldmaking
25%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Cancer
20%
Amoxicillin
20%
Antibiotics
20%
Antimicrobial Resistance
40%
Clarithromycin
100%
Diseases
100%
Helicobacter Infection
20%
Helicobacter Pylori
100%
Infection
20%
Metronidazole
20%
Prevalence
20%
Proton Pump Inhibitor
20%
Medicine and Dentistry
Abdominal Cancer
20%
Amoxicillin
20%
Antibiotic Resistance
40%
Antibiotics
20%
Clarithromycin
100%
Disease Management
100%
Helicobacter Infection
20%
Helicobacter Pylori
100%
Infection
20%
Metronidazole
20%
Prevalence
20%
Proton-Pump Inhibitor
20%
Immunology and Microbiology
Antimicrobial Resistance
33%
Helicobacter Pylori
100%
Prevalence
16%